Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Tax Season & the ACA

Kaiser Daily Global Health Policy ReportVaccines Search Results « » The Henry J. Kaiser Family Foundation

Vaccines

  • your selections
Clear Search

Filter Results

date

Tags

  • results
The Henry J. Kaiser Family Foundation

GHTC Provides Roundup Of Recent Global Health Research News

Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: clinical trials for experimental Ebola vaccines, genetic traits that affect malaria risk, and progress toward a hookworm vaccine Kat Kelley, senior program assistant at GHTC, highlights some of the past week’s news in global health research (3/30).

News Summary Read More
The Henry J. Kaiser Family Foundation

Vigilance Needed To Prevent Polio Re-emergence In Ukraine

GlobalPost: In the midst of conflict, Ukraine’s children are vulnerable to polio outbreak John Hewko, general secretary of Rotary International “While the global health community has been rightly focused on containing West Africa’s deadly Ebola outbreak, a potential health crisis involving another infectious virus — polio — worries many of…

News Summary Read More
The Henry J. Kaiser Family Foundation

Gavi, The Vaccine Alliance Aims To Immunize 300M More Children

Huffington Post: Be Bold: How Gavi Will Immunize Another 300 Million Children Dagfinn Høybråten, Secretary General for the Nordic Council of Ministers and Chair of the Gavi, the Vaccine Alliance Board “A challenge stands before us: ensuring immunization of the world’s poorest children. If we as global citizens can meet…

News Summary Read More
The Henry J. Kaiser Family Foundation

USG Awards Pharmaceutical Company Funds To Develop Ebola Treatment

The Hill: Feds award company up to $35M to develop Ebola drug “The Department of Health and Human Services (HHS) on Tuesday awarded about $12 million to a North Carolina pharmaceutical company that has been developing Ebola treatments. The company, BioCryst Pharmaceuticals, has created a ‘promising’ experimental drug that prevents…

News Summary Read More
The Henry J. Kaiser Family Foundation

Cameroon No Longer A Polio Exporting Country, But Still Considered High-Risk, Health Official Says

VOA News: Cameroon No Longer a Polio Exporter “Cameroon said it has attained the status of a ‘non-polio exporting country’ — hitting the 6-month mark without a new case — but the country is still considered a high-risk nation with pockets of resistance to polio vaccination programs for children –…

News Summary Read More
The Henry J. Kaiser Family Foundation

Ebola Vaccine Trials Show Promise, Scientists Say

VOA News: Ebola Vaccine Trials Underway in West Africa “…Since last summer, researchers have rushed to get anti-Ebola vaccines into clinical trials. While it’s too early to say that any of the potential vaccines work, some scientists say they are seeing strong results from some of the studies…” (Pearson, 3/30).

News Summary Read More
The Henry J. Kaiser Family Foundation

India Marks One Year Since Country Officially Certified Polio-Free

Bill & Melinda Gates Foundation’s “Impatient Optimists”: India’s Polio Eradication Campaign: Behind the Scenes Gillian Leitch and Mary Robbins, both senior associates with Global Health Strategies, and Leah Sandals and Rachel Sam, both managers with Global Health Strategies, discuss India’s successful efforts to eradicate polio as well as keep the…

News Summary Read More
The Henry J. Kaiser Family Foundation

Britain Reaches Agreement With GSK, Announces It Will Provide Routine Meningitis B Vaccinations

Associated Press: Britain to offer all infants meningitis B vaccine “Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC…” (3/29). Financial Times: Medics welcome GSK deal to provide meningitis B vaccine…

News Summary Read More
The Henry J. Kaiser Family Foundation

NIH Confirms Safety Of 2 Experimental Ebola Vaccines

Reuters: Two experimental Ebola vaccines pass safety test in African trial “Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, ‘appear to be safe’ part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said…

News Summary Read More
The Henry J. Kaiser Family Foundation

Guinea Begins Ebola ‘Ring Vaccination’ Trial; Chinese Researchers Report Results From Another Vaccine Trial

CIDRAP News: Ebola vaccine trial launches in Guinea; Chinese vaccine test detailed “In an effort to see if a vaccine might be used to drown out Ebola flare-ups, a new trial launched in an area of Guinea where cases have occurred recently, while Chinese researchers reported the first human trial…

News Summary Read More